CLEO: 2012 Press Luncheon Spotlights New Developments in Biophotonics for Cancer Detection, Diagnosi


FOR IMMEDIATE RELEASE

Media contacts:
Nadine Tosk
847.920.9858
nadinepr@gmail.com

Angela Stark
CLEO: 2012
202.416.1443
astark@osa.org

Wendy Lienhart
630.920.0182
wendylienhart@earthlink.net

CLEO: 2012 Press Luncheon Spotlights New Developments in Biophotonics for Cancer Detection, Diagnosis and Treatment

Premier International Forum for Lasers and Electro Optics Features Esteemed Researchers

SAN JOSE, May 2—CLEO: 2012, the Conference on Lasers and Electro Optics, brings together the world’s foremost scientists and engineers working in the field of laser science.  From May 6 – 11 in San Jose, more than 1,800 technical presentations, with content stemming from fundamental laser science to photonic applications and products will be presented in fields such as ultrafast lasers, energy-efficient optics, quantum electronics, biotechnology and more.

Hot topics in the field of biophotonics will be presented to the media and analysts in a special lunch event on Wednesday, May 9 from 12 – 1 p.m. in the San Jose Convention Center. The press program—titled Biophotonics for Cancer Detection, Diagnosis and Treatment—boastsa panel of three leading biomedical scientists who will present seminal research in the biomedical field. It will be moderated by Marcos Dantus, University Distinguished Professor at Michigan State University and president and CEO of BioPhotonic Solutions, Inc. Talks will focus on emerging cancer diagnostics and treatments driven by advances in optical laser technology, including:

  • Coherence Imaging for Early Cancer Detection: Several spectroscopic coherence imaging methods have been developed to detect pre-cancerous cells by isolating scattering signatures from specific tissue locations. These approaches and recent clinical results will be described by Adam Wax, associate professor, Department of Biomedical Engineering, Duke University.

  • Image-Guided Spectroscopy of Cancer: Translating Optical Technology into Clinical Tools: Integration of localized molecular spectroscopy into standard medical imaging instrumentation has been slow in developing, yet today there have been major developments which make it achievable on a routine basis, with surgery and interventional imaging being the primary pathways. Presented by Brian Pogue, professor of engineering and dean of graduate studies, Thayer School of Engineering, Dartmouth College.

  • Molecular Spectroscopy and Imaging: A Multi-Billion Dollar Industry Reshaping Biotech and Medicine.  David Benaron, founder of the Stanford Biophotonics Group, professor at the Stanford School of Medicine, and CEO of Spectros Corporation, will discuss how the ability to detect and image biology at a level specific to the molecule, pathway, or cell is providing a new boom in biotechnology—with optics playing a key role as this area expands.

  • Optical Coherence Tomography (OCT) is an emerging technology for performing high-resolution cross-sectional imaging. OCT is analogous to ultrasound imaging, except that it uses light instead of sound. Where standard excisional biopsy is risky or impossible, OCT allows clinicians to reduce sampling errors associated with excisional biopsy, and to guide interventional procedures. Moderator Marcos Dantus will present on OCT as it relates to his company’s 2012 CLEO/Laser Focus World Innovation Award-winning device, the femtoAdaptiv™, the first ultrafast laser capable of adaptive pulse self-compression.

Interview Opportunities:  Papers and additional information are available. CLEO presenters are available by phone and on-site in San Jose for interviews. Contact Nadine Tosk, nadinepr@gmail.com.  

Complimentary Press Registration: To join your peers at CLEO, register now for the meeting and plan to attend the press luncheon on Wednesday.  Simply fill out the online form and you’ll receive a confirmation email within 72 hours.

About CLEO

With a distinguished history as the industry's leading event on laser science, the Conference on Lasers and Electro-Optics (CLEO) is where laser technology was first introduced. CLEO unites the field of lasers and electro-optics by bringing together all aspects of laser technology, with content stemming from basic research to industry application. CLEO: Expo showcases the latest products and applications from more than 300 participating companies from around the world, providing hands-on demonstrations of the latest market innovations and applications. The Expo also offers valuable on-floor programming, including Market Focus and the Technology Transfer program.

Sponsored by the American Physical Society's (APS) Laser Science Division, the Institute of Electronic Engineers (IEEE) Photonics Society and the Optical Society (OSA), CLEO provides the full range of critical developments in the field, showcasing the most significant milestones from laboratory to marketplace. With an unparalleled breadth and depth of coverage, CLEO connects all of the critical vertical markets in lasers and electro-optics. For more information, visit the conference's website at www.cleoconference.org.

###